119 related articles for article (PubMed ID: 16815344)
1. Review of therapies for immune thrombocytopenic purpura.
Bussel J; Tarantino M
Semin Hematol; 2006 Jul; 43(3 Suppl 5):S1-2. PubMed ID: 16815344
[No Abstract] [Full Text] [Related]
2. New therapies for immune thrombocytopenic purpura.
Andemariam B; Bussel J
Curr Opin Hematol; 2007 Sep; 14(5):427-31. PubMed ID: 17934347
[TBL] [Abstract][Full Text] [Related]
3. New treatment options for immune-mediated hematological disorders.
Dierickx D; De Rycke A; Vanderschueren S; Delannoy A
Eur J Intern Med; 2008 Dec; 19(8):579-86. PubMed ID: 19046722
[TBL] [Abstract][Full Text] [Related]
4. Current options for the treatment of idiopathic thrombocytopenic purpura.
Arnold DM; Kelton JG
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
[TBL] [Abstract][Full Text] [Related]
5. Splenectomy for treatment of immune thrombocytopenic purpura.
Malcovati L; Della Porta MG
Haematologica; 2005 Jan; 90(1):4. PubMed ID: 15644305
[No Abstract] [Full Text] [Related]
6. Treatment of immune thrombocytopenic purpura in adults.
Bussel J
Semin Hematol; 2006 Jul; 43(3 Suppl 5):S3-10; discussion S18-9. PubMed ID: 16815346
[TBL] [Abstract][Full Text] [Related]
7. Anti-interleukin-2 receptor antibody (daclizumab) treatment of corticosteroid-refractory autoimmune thrombocytopenic purpura.
Fogarty PF; Seggewiss R; McCloskey DJ; Boss CA; Dunbar CE; Rick ME
Haematologica; 2006 Feb; 91(2):277-8. PubMed ID: 16461323
[TBL] [Abstract][Full Text] [Related]
8. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
9. Management of immune thrombocytopenic purpura in pregnancy.
Sukenik-Halevy R; Ellis MH; Fejgin MD
Obstet Gynecol Surv; 2008 Mar; 63(3):182-8. PubMed ID: 18279544
[TBL] [Abstract][Full Text] [Related]
10. Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab.
Iesato K; Hatakeyama N; Yamamoto M; Hori T; Inazawa N; Tsutsumi H; Suzuki N
Pediatr Blood Cancer; 2009 Aug; 53(2):203-5. PubMed ID: 19301247
[TBL] [Abstract][Full Text] [Related]
11. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab.
Kuwana M; Iki S; Urabe A
Am J Hematol; 2007 Sep; 82(9):846-8. PubMed ID: 17506067
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic thrombocytopenic purpura: a revolution of biological therapy?].
Bierling P; Godeau B
Rev Prat; 2009 May; 59(5):606-7. PubMed ID: 19552194
[No Abstract] [Full Text] [Related]
13. Idiopathic thrombocytopenic purpura: preliminary results in patients aged >65 years.
Andrès E; Daou S; Federici L; Zimmer J
QJM; 2007 Apr; 100(4):249. PubMed ID: 17369620
[No Abstract] [Full Text] [Related]
14. Recent advances in the treatment of childhood immune thrombocytopenic purpura.
Tarantino M
Semin Hematol; 2006 Jul; 43(3 Suppl 5):S11-7; discussion S18-9. PubMed ID: 16815345
[TBL] [Abstract][Full Text] [Related]
15. [Immune thrombocytopenic purpura: pathophysiology and treatment].
Godeau B
Transfus Clin Biol; 2009 May; 16(2):101-5. PubMed ID: 19409827
[TBL] [Abstract][Full Text] [Related]
16. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?
Cooper N; Evangelista ML; Amadori S; Stasi R
Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency.
Mahévas M; Le Page L; Salle V; Cevallos R; Smail A; Duhaut P; Ducroix JP
Am J Hematol; 2006 Aug; 81(8):645-6. PubMed ID: 16823831
[No Abstract] [Full Text] [Related]
18. [New development in the treatment of idiopathic thrombocytopenic purpura].
Kurata Y
Nihon Naika Gakkai Zasshi; 2000 Jun; 89(6):1114-20. PubMed ID: 10892186
[No Abstract] [Full Text] [Related]
19. Diagnosis, pathophysiology and management of children with refractory immune thrombocytopenic purpura.
Kalpatthi R; Bussel JB
Curr Opin Pediatr; 2008 Feb; 20(1):8-16. PubMed ID: 18197033
[TBL] [Abstract][Full Text] [Related]
20. Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura.
Fianchi L; Rossi E; Murri R; De Stefano V; Pagano L; Leone G
Ann Hematol; 2007 Mar; 86(3):225-6. PubMed ID: 17031685
[No Abstract] [Full Text] [Related]
[Next] [New Search]
